Work

A phase II study of celecoxib (C) with irinotecan (I), 5-fluorouracil (F), and leucovorin (L) in patients (pts) with advanced or metastatic colorectal cancer (CRC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.3588

Authors: R. E. Sanborn, H. Lenz, D. G. Haller, A. B. Benson, T. Dragovich, C. Robles, M. McMahon, H. Li, M. Mori, N. Mattek, C. D. Blanke

Institutions: Northwestern University, University of Southern California, Oregon Health & Science University, USC Norris Comprehensive Cancer Center, University of Pennsylvania

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249830532

Cites:

Cited by:

Related to: 10